Latest news
Mirum Pharmaceuticals (MIRM) Is Down 5.0% After Wider Losses and Volixibat Delay - What's Changed - simplywall.stsimplywall.st · Sat, 08 Aug 2026 07:38:07 GMTA Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $118 to $140 - MoomooMoomoo · Fri, 07 Aug 2026 22:03:25 GMTMIRM Aug 2026 115.000 put (MIRM260821P00115000) stock historical prices and data - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 20:37:45 GMTMIRM Stock Clocks Best Day In 4.5 Months On Liver Disease Trial Data: Retail Eyes Buyout At A Premium - StocktwitsStocktwits · Fri, 07 Aug 2026 07:24:09 GMTCitizens Says FDA’s 'Unexpected' Phase 3 Request Clouds Mirum’s Near-Term Outlook – MIRM Stock Crashes 15% - StocktwitsStocktwits · Fri, 07 Aug 2026 06:25:08 GMTMirum Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $138.21, Implies 31% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:21 GMTMirum's Q2 Earnings Lag Estimates, Revenues Beat, 2026 View Raised - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 15:21:00 GMTFMR LLC reveals 6.2% Mirum Pharmaceuticals (MIRM) ownership in Schedule 13G - Stock TitanStock Titan · Thu, 06 Aug 2026 14:34:54 GMT